透皮
化学
角质层
渗透
泊洛沙姆
自愈水凝胶
两亲性
胶束
离体
体内
药物输送
跨细胞
生物物理学
毒品携带者
鼻腔给药
药理学
口腔给药
色谱法
生物利用度
泊洛沙姆407
共聚物
剂型
药品
纳米技术
卵磷脂
聚乙烯吡咯烷酮
互连性
药代动力学
纳米载体
微粒
小泡
亲脂性
作者
Yuan Wang,Songmei Luo,Lu Wang,Yansong Zhang,Ruhui Yang,Yuhao Jiang,Jingjing Guo,Xingjie Zan,Sicheng Tang,Kejun Cheng
出处
期刊:Biomacromolecules
[American Chemical Society]
日期:2026-08-11
卷期号:27 (9): 5934-5947
标识
DOI:10.1021/acs.biomac.6c00656
摘要
Noninvasive transdermal drug delivery (TDD) offers sustained therapeutic release but is hindered by the stratum corneum (SC) barrier. Herein, we report ultrasmall polymeric micelles (PMs) embedded in poly(vinyl alcohol) hydrogels for the passive TDD of rosiglitazone (RGT) to treat Type 2 diabetes mellitus (T2DM). We synthesized amphiphilic brush copolymers with varied hydrophobic cores (linear alkanes, benzene, borneol) to tune SC interactions and ensure colloidal stability. Ex vivo murine skin studies demonstrated that PM variants with C10 alkane and benzene cores achieved 10.56% and 19.84% cumulative permeation at 24 h, respectively, via dual paracellular/intracellular routes. In vivo, PM hydrogels delivered steady plasma accumulation. In a T2DM model, transdermal RGT reduced blood glucose by 30% over 12 days without observable skin or organ toxicity. This nanoplatform enables noninvasive systemic delivery, offering a robust alternative to oral administration for sustained glycemic control.
科研通智能强力驱动
Strongly Powered by AbleSci AI